ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Discover which travel rewards credit cards come with no fees. Enjoy your travels while saving money on fees.
26,830 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
May presents a compelling setup for investors seeking durable growth. This guide breaks down the three key reasons wh...
Nvidia’s growth has stunned the market, but a new pledge from Jensen Huang signals a major shift in capital returns. ...
SpaceX led a historic IPO moment, but inflation is heating up alongside. This guide breaks down what that means for y...
Cerebras stock is climbing as fresh news and growing AI demand spark investor excitement. This guide breaks down the ...
A major portfolio pivot is unfolding as 13F data reveals a famous hedge fund manager changing course. Learn why billi...
As NIO reports its first quarterly profit, the market weighs durability vs. growth. This in-depth look breaks down ho...
As the AI rally fans the markets, the boom looks like dot-com. Yet Bitcoin bulls point to a tangible edge—scarcity an...
As SpaceX eyes a historic float, investors are handed a high-stakes mix of dream-scale growth and sobering risk. This...
IonQ shows a real enterprise backlog totaling hundreds of millions, while Rigetti burns cash with declining revenue. ...
A growing trend centers on the HSA receipt trick: medical bills, a tax-free growth strategy that lets you reimburse p...
A veteran Jefferies strategist outlines a split AI spend cycle: upfront hardware capex drives early gains, while long...